Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Brain Stem Neoplasms
- Anlotinib to Malignant Brainstem Glioma
- A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation
- Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring Platelet-Derived Growth Factor Receptor (PDGFR) Alterations
- Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
- Nimotuzumab in Combination With Radio-chemotherapy for the Treatment of Brainstem Tumor in Children
- Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors
- p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors
- Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors
- A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors
- Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma